Published in Curr Opin Neurol on June 01, 2011
JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J Cell Physiol (2012) 0.92
JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication. Virology (2012) 0.89
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient. PLoS One (2012) 0.87
Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts. Virology (2013) 0.86
Rad51 activates polyomavirus JC early transcription. PLoS One (2014) 0.81
Prevalence of JC virus in Chinese patients with colorectal cancer. PLoS One (2012) 0.80
Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an α-helix encompassing the Leu/Ile/Phe-rich domain. J Virol (2014) 0.77
Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release. J Cell Physiol (2017) 0.75
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol (2006) 1.34
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Isolated Histoplasma capsulatum meningoencephalitis in an immunocompetent child. J Child Neurol (2012) 0.94
Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Trends Neurosci (2002) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
The bone marrow, B cells, and JC virus. J Neurovirol (2008) 0.93
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol (2010) 0.93
Steroids for PML-IRIS: a double-edged sword? Neurology (2009) 0.89
Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneap Minn) (2015) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. Arch Pathol Lab Med (2012) 0.86
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neurovirol (2006) 0.86
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. Am J Otolaryngol (2010) 0.86
Progressive multifocal leukoencephalopathy in multiple sclerosis. Curr Neurol Neurosci Rep (2013) 0.85
Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. Curr Treat Options Neurol (2012) 0.85
Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy (2006) 0.85
Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J (2002) 0.84
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. AIDS (2003) 0.83
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review. J Neuroophthalmol (2015) 0.83
Infection risk in patients on multiple sclerosis therapeutics. CNS Drugs (2015) 0.81
Substantia nigra depigmentation and exposure to encephalitis lethargica. Ann Neurol (2012) 0.81
Spinal epidural abscess. Curr Infect Dis Rep (2014) 0.81
Alien hand syndrome. Neurology (2006) 0.81
Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology (2003) 0.79
Disease-modifying drugs for multiple sclerosis and JC virus expression. J Neurovirol (2012) 0.79
Introduction to HIV infection and neuro-AIDS. Handb Clin Neurol (2007) 0.79
The manifold faces of PML and the challenge of diagnosis. Neurology (2011) 0.79
The changing landscape of progressive multifocal leukoencephalopathy. Curr Infect Dis Rep (2011) 0.79
Reply to "'Thinking without thinking' about natalizumab and PML". J Neurol Sci (2007) 0.78
Autoimmune markers in HIV-associated dementia. J Neuroimmunol (2003) 0.78
An international screening tool for HIV dementia. AIDS (2005) 0.78
Primary lateral sclerosis with HIV-1 infection. Neurology (2008) 0.77
Too much of a good thing? IRIS with natalizumab-associated PML. Neurology (2011) 0.77
HIV and the central nervous system. Compr Ther (2002) 0.77
Identification of potential antibody markers in HIV-associated dementia. J Neuroimmunol (2004) 0.76
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. AIDS (2010) 0.76
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol (2014) 0.75
Parinaud syndrome heralding MS. Neurology (2003) 0.75
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? Neurology (2007) 0.75
Memory and the mammillothalamic tract. AJNR Am J Neuroradiol (2004) 0.75
Acute central cord syndrome with bodybuilder sign. Clin Neurol Neurosurg (2007) 0.75
Progressive multifocal leukoencephalopathy. Handb Clin Neurol (2007) 0.75
Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT. Clin Neurol Neurosurg (2008) 0.75
Volitional opsoclonus. Neurology (2005) 0.75
Neuro-AIDS in the developing world. Neurology (2012) 0.75
A giant MS plaque mimicking PML during natalizumab treatment. J Neurol Sci (2010) 0.75
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. J Neurovirol (2002) 0.75
Infectious myelopathies. Continuum (Minneap Minn) (2011) 0.75
Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep (2013) 0.75
Homonymous hemianopsia complicating treatment of postoperative epistaxis. Neurology (2006) 0.75
Against all odds: surviving rhino-orbital-cerebral mucormycosis: a case report. J Neurovirol (2012) 0.75
The interface of infectious disease and neuro-ophthalmology. J Neuroophthalmol (2012) 0.75
Other opportunistic infections of the central nervous system in AIDS. Handb Clin Neurol (2007) 0.75
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient. J Neurovirol (2014) 0.75